Main Article Content

Abstract

This study aimed to determine the relationship between mothers with history of diabetes mellitus with Infants with Anti-GAD65. This study was an observational analytic study with a cohort study design. The case studied was the relationship between maternal history of diabetes mellitus and infants with Anti-GAD65. This study was conducted at Jemursari Hospital in Surabaya. Sample examination was performed with a GAD65 autoimmune rapid test. Then, a statistical test was performed to determine its relationship with other variables. There was no relationship between mothers with history of diabetes mellitus and infants with Anti-GAD65, but there was a significant relationship between Anti-GDA65 Mothers with Infants with Anti-GAD65. Thus, there was a possibility of transplacental antibody transfer and viral infections during pregnancy that cause damage to pancreatic beta cells. History of diabetes mellitus was not related to infants with Anti-GAD65, but there was a relationship between Anti-GAD65 Mothers with Anti-GAD65 BAyi so that there is a transfer of transplacenta antibodies and viral infections during pregnancy that can cause damage to beta pancreatic cells in infants.

Keywords

Diabetes mellitus GAD65 transplacental antibodies virus infection pregnancy

Article Details

How to Cite
Salamy, N. F. W., Sari, G. M., Purwanto, B., & Sulistiawati, S. (2019). Correlation of Mothers with History of Diabetes Mellitus and Infants with Anti-GAD65. Folia Medica Indonesiana, 55(4), 301–305. https://doi.org/10.20473/fmi.v55i4.24474

References

  1. Ahlqvist E, Ahluwalia TS, Groop L (2011). Genetics of type 2 diabetes. Clinical Chemistry 57, 241-254
  2. American Diabetes Association (2012). Diagnosis and classification of diabetes mellitus. Diabetes Care 35, 64-71
  3. American Diabetes Association (2013). Standards of medical care in diabetes 2013. Diabetes Care 36, 11-66
  4. Baekkeskov S, Aanstoot H-J, Christgau S, Reetz A, Solimena M, Cascalhom, Folli F, Ritcher Olesen H, De Camilli P (1990). Identification of the 64K autoantigen in insulin-diabetes as the GABA-synthesizing enzyme glutamic acid decarboxylase. Nature (Lond) 347, =151-56
  5. Banatvala JE, Bryant J, Schernthaner G, Borkenstein M, Schober E, Brown D, De Silva LM, Menser MA, Silink M (1985). Coxsackie B, mumps, rubella, and cytomegalovirus specific IgM responses in patients with juvenileonset insulin-dependent diabetes mellitus in Britain, Austria, and Australia. Lancet 1, 1409-1412
  6. Clements GB, Galbraith DN, Taylor KW (1995). Coxsackie B virus infection and onset of childhood diabetes. Lancet 346, 221-223
  7. Coppieters KT, Wiberg A, von Herrath MG (2012). Viral infections and molecular mimicry in type 1 diabetes. APMIS 120, 941-949
  8. Coppieters KT, Dotta F, Amirian N, Campbell PD, Kay TW, Atkinson MA, ,Roep BO, Von Herrath MG (2012). Demonstration of islet- autoreactive CD8 T cells ininsulitic lesions from recent onset and long-term type 1 diabetes patients. The Journal of Experimental Medicine 209, 51-60
  9. Erlander MGNJK. Tillakaratne S. Feldblum N, et al (1991). Two genes encode distinct glutamate decarboxylases with different responses to pyridoxal phosphate. Neuron 7, 91-100
  10. Fujinamia RS, Von Herrath MG, Christen URS, Whitton JL (2006). Molecular mimicry, bystander activation, or viral persistence infections and autoimmune disease. Clinical Microbiology Review, 80-94
  11. Hamalainen AM, Ronkainen MS, Akerblom HK, Knip M (2000). Postnatal elimination of transplacentally acquired disease-associated antibodies in infants born to families with type 1 diabetes: the Finnish TRIGR Study Group: Trial to Reduce IDDM in the Genetically at Risk. J Clin Endocrinol Metab 85, 4249-4253
  12. Juneja R, Hirsch IB, Naik RG, et al (2001). Islet cell antibodies and glutamic acid decarboxylase antibodies, but not the clinical phenotype, help to identify type 1(1/2) diabetes in patients presenting with type 2 diabetes. Metabolism 50, 1008-1013
  13. Koczwara KE, Bonifacio, Ziegler AG (2004). Transmission of maternal islet antibodies and risk of autoimmune diabetes in offspring of mothers with type 1 diabetes. Diabetes 53, 1-4
  14. Leiser R, Kaufmann P (1994). Placental structure: In a comparative aspect. experimental and clinical endo-crinology, 102, 122-134. http://dx.doi.org/10.1055/s-0029-1211275
  15. Newsholme P, Keane K, et al (2013). The impact of inflammation on pancreatic íŸ-cell metabolism, function and failure in T1DM and T2DM: Commonalities and differences. Intech
  16. Ozougwu KC, Obimba CD, Belonwu CB, Unakalamba (2013). The pathogenesis and pathophysiology of type 1 and type 2 diabetes melitus J. Physiol. Pathophysiol 4, 46-57
  17. Pociot F, McDermott MF (2002). Genetics of type 1 diabetes mellitus (Review). Genes Immun 3, 235-249
  18. Pranoto A, Sutjahjo A, Tjokroprawiro A, Murtiwi S, Wibisono S (2011). Konsensus pengelolaan dan pencegahan diabetes melitus tipe 2 di Indonesia 2011. LPPM , Universitas Airlangga, Surabaya
  19. Serreze DV, Ottendorfer EW, Ellis TM, Gauntt CJ, Atkinson MA (2000). Acceleration of type 1 diabetes by a coxsackievirus infection requires a preexisting critical mass of autoreactive T-cells in pancreatic islets. Diabetes 49, 708-711
  20. Shulman LM, Hampe CS, Ben- Haroush A, et al (2014). Antibodies to islet cell autoantigens, rota-viruses and/or enteroviruses in cord blood and healthy mothers in relation to the 2010-2011 winter viral seasons in Israel: a pilot study Diabet Med 31, 681-685
  21. Tedjapranata M (2009). Diabetes di usia lanjut memang berbahaya, namun dapat dijinakkan. Available at: http://www.gbimawarsaron.com/kesehatan/27-diabe-tes- mellitus. Accesed March 12, 2016
  22. Tuomi T, Carlsson í…, Li H, Isomaa A, Miettinen A, Nissén M, Ehrnström B-J, Forsén B, Snickars B, Lahti K, Forsblom C, Saloranta C, Taskinen M-R, Groop LC (1999). Clinical and genetic characteristics of type 2 diabetes with and without GAD antibodies. Diabetes 48, 150-157
  23. Uibo R, Lernmark A (2008). GAD65 autoimmunity-clinical studies. Adv Immunol 100, 39-78
  24. WHO (1999). Definition, diagnosis and classification of diabetes mellitus and its complications, report of a WHO Consultation World Health Organization, De-partment of Non communicable Disease Surveillance, Geneva